Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The retinoid nuclear receptor pathway is a signaling cascade mediated by RAR and RXR nuclear receptors, activated by retinoids (vitamin A derivatives). It regulates gene expression, influencing development, cell fate, immunity, and metabolism. Dysregulation is linked to various diseases, including cancer, metabolic disorders, and developmental abnormalities. The pathway is considered a signaling pathway, not a direct therapeutic target, because drugs target the receptors within the pathway.
Ligand-dependent activation of RAR/RXR heterodimers, leading to altered gene transcription
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinoid Nuclear Receptor Pathway (Retinoid Pathway).